Walgreens Boots Alliance Moves Closer to $8.9 Billion Acquisition of Boots with Legal Giants at Helm

The competitive landscape of the pharmaceutical and retail sectors is seeing a significant shift as Walgreens Boots Alliance Inc. nears the acquisition of Boots, its UK-based pharmaceutical arm. This $8.9 billion transaction is being facilitated by top-tier legal advisors, underscoring the complexity and magnitude of the deal. Davis Polk & Wardwell LLP, Skadden, Arps, Slate,…

Read More

Illinois Court Limits Covid-Era Immunity for Healthcare Workers: Implications for Ongoing Legal Cases

The Illinois Appellate Court recently issued a decision that narrows the scope of Covid-era immunity defenses for healthcare professionals, reviving legal claims against a nurse accused of negligence during the pandemic. This decision has significant implications, potentially affecting nearly a dozen pending cases in which similar immunity defenses have been invoked by healthcare providers. According…

Read More

Squire Patton Boggs Enhances D.C. Public Policy Practice with Key Hires Amid Regulatory Changes

Squire Patton Boggs, a globally recognized law firm, has expanded its public policy capabilities by welcoming two seasoned professionals to its Washington DC office. These additions highlight the firm’s commitment to bolstering its presence in the strategic public policy arena, particularly in the nation’s capital. The firm recently announced the onboarding of these experts who…

Read More

UN Condemns Deadly Airstrike on Humanitarian Aid Convoys in Sudan’s Escalating Crisis

The United Nations World Food Programme (WFP) has issued a condemnation following a deadly airstrike on two humanitarian aid trucks in South Kordofan, Sudan. The attack, which took place early Saturday, tragically resulted in the death of one of the drivers. The trucks, clearly marked as humanitarian vehicles, were transporting food and essential commodities to…

Read More

Baker McKenzie Boosts Congressional Investigations Team Amid Rising Demand for Regulatory Expertise

Baker McKenzie is enhancing its Congressional investigations practice with a strategic hire, underscoring its commitment to handling intricate legislative inquiries. The firm has brought onboard a high-profile expert to spearhead this effort, aligning with its broader strategy to expand capabilities in areas intersecting with public policy and regulatory compliance. According to Bloomberg Law, the new…

Read More

DOJ Launches National Fraud Enforcement Division to Intensify Fight Against Government Fraud

The U.S. Department of Justice (DOJ) has launched the National Fraud Enforcement Division, which aims to function as a “full-fledged law firm” laser-focused on combating government fraud. In just under six months, this initiative is already influencing the department’s structure and instigating a rise in internal investigations within corporations, according to insights from white-collar experts….

Read More

Federal Challenge Set to Review Impact of Medicare Drug Price Rules on Pharmaceutical Stability

In a significant development, the federal government has requested the full D.C. Circuit to review a decision regarding Teva Pharmaceuticals’ ability to contest Medicare’s drug pricing rules. This appeal follows a panel ruling permitting Teva to challenge the criteria Medicare employs to determine which drugs are eligible for price negotiations. The government argues that this…

Read More

Miller & Chevalier Expands Healthcare Fraud Expertise with DOJ Veteran Appointment

Miller & Chevalier Chartered has announced the addition of a key player from the U.S. Department of Justice, marking a strategic expansion of their litigation capabilities. The firm welcomed a former deputy chief from the National Fraud Enforcement Division’s Health Care Fraud Section, who will bolster their healthcare fraud expertise. This move underscores Miller &…

Read More

Challenges Persist in Delivering Humanitarian Aid to Gaza Despite Ceasefire Agreement, UN Reports

The United Nations reports that the flow of humanitarian aid to Gaza continues to face significant hurdles, despite a ceasefire agreement reached nearly a year ago. Palestinians in the region remain challenged by deprivation of basic human rights, particularly regarding access to essential services such as water, housing, healthcare, and education. As the UN strives…

Read More

Federal Court Blocks Trump’s H-1B Visa Fee, Citing Procedural Violations and Overreach

In a significant legal development, the US District Court for the Northern District of California has blocked President Donald Trump’s imposition of a $100,000 fee on H-1B visas for highly skilled foreign workers. This decision marks the second federal court injunction against the policy, which critics argue was enacted without proper congressional authorization. The injunction…

Read More

Federal Judge Rules Against Liquidia in Pulmonary Hypertension Patent Dispute

In a significant development for the pharmaceutical industry, a Delaware federal judge has determined that Liquidia Technologies infringed upon a patent that protects methods for treating pulmonary hypertension associated with interstitial lung disease. This conclusion stems from Liquidia’s attempts to secure approval for Yutrepia, a drug designed to address this medical condition. The ruling reinforces…

Read More

Court Halts Biosimilar Launch: Janssen Biotech Wins Temporary Restraining Order Against Accord BioPharma

In a recent development from the U.S. District Court in Delaware, a temporary restraining order has been granted to Janssen Biotech, effectively stalling Accord BioPharma’s efforts to produce a biosimilar to its flagship arthritis medication, Simponi. This decision is pivotal as it underscores the ongoing battles within the pharmaceutical industry over patent rights and the…

Read More

New Jersey Court Rules in Favor of FBT Gibbons LLP, Allowing Continued Representation of Cigna in Underpayment Dispute

A New Jersey state court has denied a motion to disqualify FBT Gibbons LLP from representing Cigna and associated employer-sponsored health plans in a lawsuit concerning alleged underpayments to a plastic surgery practice. The court determined that the motion appeared to be an attempt to gain a strategic advantage rather than to protect client interests….

Read More

Global M&A Deal Volume Declines by 10% Amid Economic and Regulatory Challenges

The mergers and acquisitions (M&A) landscape is facing a challenging period as global deal volumes have seen a noticeable decline of 10%, marking a considerable setback for dealmakers who had initially anticipated a record year. This downturn is primarily attributed to mounting economic uncertainties and more stringent regulatory environments, impacting the appetite and confidence of…

Read More

Greenberg Traurig Strengthens FDA Regulatory Practice with Key Hire in Washington, D.C.

Greenberg Traurig, a high-profile international law firm, has strategically expanded its capabilities in FDA regulatory matters by welcoming Barbara J. Binagwaho Javitt to their Washington, D.C. office. Javitt, previously an integral part of Hyman, Phelps & McNamara, is renowned for her adeptness in navigating FDA guidelines and regulatory landscapes. Her appointment is poised to enhance…

Read More

Lebanon’s Conflict Deepens Child Hunger Crisis: UNICEF Report Highlights Unyielding Struggle for Survival

The ongoing conflict in Lebanon has drastically impacted the humanitarian situation, particularly for children. The United Nations Children’s Fund (UNICEF) reveals in a recent report that more than one in five Lebanese households surveyed have children who have gone to bed hungry. This alarming statistic underscores the severe toll on children’s access to fundamental needs…

Read More

Biosimilars Market Grows as M&A Activity Surges Amid Patent Expirations and Regulatory Changes

The biosimilars sector is currently navigating a pivotal moment marked by increased mergers and acquisitions activity. In the first nine months of 2026 alone, deal value in this market reached approximately $13 billion, following a 15% year-over-year increase in average transaction size since 2025. This upward trend highlights the strategic importance of biosimilars as a…

Read More

Armstrong Teasdale Expands Chicago Corporate Services with Strategic M&A Hires

Armstrong Teasdale LLP has bolstered its corporate services team in Chicago by welcoming a new partner from Polsinelli PC and a counsel from McDonald Hopkins LLC, as announced recently. This strategic expansion underscores the firm’s commitment to strengthening its mergers and acquisitions (M&A) capabilities in a competitive legal market. The strategic hires come amidst a…

Read More

New Jersey Court Advances Antitrust Case Against Celgene and Partners Over Revlimid Pricing Practices

In a notable development within the pharmaceutical industry, a New Jersey federal judge has denied motions to dismiss a complex antitrust multidistrict litigation (MDL) involving Celgene Corp.’s cancer medication Revlimid. The litigation accuses Bristol-Myers Squibb, Natco Pharma, AbbVie, and other pharmaceutical companies of engaging in “pay-for-delay” agreements, which allegedly delayed the entry of generic competitors…

Read More